Article(id=1330183573958668902, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183519441105099, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.02.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1657555200000, receivedDateStr=2022-07-12, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070077646, onlineDateStr=2026-11-19, pubDate=1675958400000, pubDateStr=2023-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070077646, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070077646, creator=13701087609, updateTime=1795070077646, updator=13701087609, issue=Issue{id=1330183519441105099, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='2', pageStart='165', pageEnd='294', issueExtLink='null', onlineDate='null', pubDate='1675958400000', pubDateStr='2023-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070064649, creator='13701087609', updateTime=1795080429540, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330226993464979643, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183519441105099, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330226993464979644, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183519441105099, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=191, endPage=199, ext={EN=ArticleExt(id=1330183574231298663, articleId=1330183573958668902, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Transdermal Drug Delivery Systems in Treatment of Mental Disorders, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
The incidence of mental disorders is high and has been increased year by year, and antipsychotics are still the main effective methods for treatment of mental disorders at present. However, traditional routes of administration(oral, injection, etc.) cannot fully meet clinical needs due to the limitations of high frequency of medication, large fluctuation in blood drug concentrations, more adverse reactions, and poor patient compliance. Transdermal drug delivery system(TDDS) is a non-invasive drug delivery method that can continuously deliver drugs, maintain stable blood drug concentrations for a long time, and discontinue the drug administration at any time. TDDS can avoid the liver first-pass effect and gastrointestinal irritation, reduce dose-related side effects of oral administration, and with better medication compliance. This paper reviews the latest research results and clinical trials of TDDS in the treatment of mental disorders, and addresses key points to consider in clinical studies of this kind of products, hoping to provide a reference for the pharmaceutical and clinical research of antipsychotics.
, authors=Zhiyuan HOU, Xiaoxiao CHENG, Qiang WEN, Hailong ZHANG, Jinsong DING
*, authorsList=Zhiyuan HOU, Xiaoxiao CHENG, Qiang WEN, Hailong ZHANG, Jinsong DING, authorCompany=null, correspAuthors=Jinsong DING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330183575162434152, articleId=1330183573958668902, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=抗精神障碍经皮递药系统的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=
精神障碍类疾病发病率高且逐年增长,而抗精神病药物仍是目前治疗精神障碍的主要手段。然而,传统给药途径(口服、注射等)因用药频率高、血药浓度波动大、不良反应多、患者依从性差等局限性而不能完全满足临床需求。经皮递药系统是一种可持续递送药物、长时间维持血药浓度稳定、可随时中止给药的无创型给药方法,可避免口服给药的肝脏首过效应和胃肠道刺激性,并减少与剂量相关的不良反应,具有更好的用药依从性。该研究综述了经皮递送药物治疗精神障碍的最新研究成果及临床试验开展情况,阐述了此类产品临床研究中的考虑要点,期望为抗精神障碍药的药学及临床研究提供参考。
, authors=侯志远, 程晓晓, 文强, 张海龙, 丁劲松
*, authorsList=侯志远, 程晓晓, 文强, 张海龙, 丁劲松, authorCompany=null, correspAuthors=丁劲松, authorNote=
侯志远(1996—),男,博士研究生,专业方向:经皮递药系统。
, correspAuthorsNote=
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=2AvagtQe2sHuN+0ZULo3KQ==, magXml=bkUNqvxwjRfJQcq6nddvYQ==, pdfUrl=null, pdf=O7IUXCrsZpN0jAsH+1WfbA==, pdfFileSize=1570266, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=uJiHpJy2Yoye3eono33QoA==, mapNumber=null, fund=null)}, authors=[Author(id=1330183575485395565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183577142145648, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183575485395565, language=EN, stringName=Zhiyuan HOU, firstName=Zhiyuan, middleName=null, lastName=HOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183577213448817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183575485395565, language=CN, stringName=侯志远, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中南大学湘雅药学院,湖南 长沙 410083, bio={"content":"
侯志远(1996—),男,博士研究生,专业方向:经皮递药系统。
"}, bioImg=null, bioContent=
侯志远(1996—),男,博士研究生,专业方向:经皮递药系统。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183575367955049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, xref=null, ext=[AuthorCompanyExt(id=1330183575380537962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083), AuthorCompanyExt(id=1330183575388926571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中南大学湘雅药学院,湖南 长沙 410083)])]), Author(id=1330183577356055156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183577444135542, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183577356055156, language=EN, stringName=Xiaoxiao CHENG, firstName=Xiaoxiao, middleName=null, lastName=CHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183577519633015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183577356055156, language=CN, stringName=程晓晓, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中南大学湘雅药学院,湖南 长沙 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183575367955049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, xref=null, ext=[AuthorCompanyExt(id=1330183575380537962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083), AuthorCompanyExt(id=1330183575388926571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中南大学湘雅药学院,湖南 长沙 410083)])]), Author(id=1330183577628684921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183577729348219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183577628684921, language=EN, stringName=Qiang WEN, firstName=Qiang, middleName=null, lastName=WEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183577863565948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183577628684921, language=CN, stringName=文强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中南大学湘雅药学院,湖南 长沙 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183575367955049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, xref=null, ext=[AuthorCompanyExt(id=1330183575380537962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083), AuthorCompanyExt(id=1330183575388926571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中南大学湘雅药学院,湖南 长沙 410083)])]), Author(id=1330183577939063422, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183578085864065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183577939063422, language=EN, stringName=Hailong ZHANG, firstName=Hailong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183578220081794, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183577939063422, language=CN, stringName=张海龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中南大学湘雅药学院,湖南 长沙 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183575367955049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, xref=null, ext=[AuthorCompanyExt(id=1330183575380537962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083), AuthorCompanyExt(id=1330183575388926571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中南大学湘雅药学院,湖南 长沙 410083)])]), Author(id=1330183578312356484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=dingjs0221@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183578413019782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183578312356484, language=EN, stringName=Jinsong DING, firstName=Jinsong, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183578471740039, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, authorId=1330183578312356484, language=CN, stringName=丁劲松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=中南大学湘雅药学院,湖南 长沙 410083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183575367955049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, xref=null, ext=[AuthorCompanyExt(id=1330183575380537962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083), AuthorCompanyExt(id=1330183575388926571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中南大学湘雅药学院,湖南 长沙 410083)])])], keywords=[Keyword(id=1330183578614346376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=EN, orderNo=1, keyword=transdermal drug delivery system), Keyword(id=1330183578756952713, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=EN, orderNo=2, keyword=antipsychotics), Keyword(id=1330183578861810314, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=EN, orderNo=3, keyword=mental disorder), Keyword(id=1330183578920530571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=EN, orderNo=4, keyword=patient compliance), Keyword(id=1330183578991833740, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=CN, orderNo=1, keyword=经皮递药系统), Keyword(id=1330183579050553997, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=CN, orderNo=2, keyword=抗精神病药), Keyword(id=1330183579109274254, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=CN, orderNo=3, keyword=精神障碍), Keyword(id=1330183579180577423, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, language=CN, orderNo=4, keyword=患者依从性)], refs=[Reference(id=1330183579289629328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=SOLMI M, RADUA J, OLIVOLA M,
et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies [J].
Mol Psychiatry, 2022,
27(1):281-295., articleTitle=null, refAbstract=null), Reference(id=1330183579352543889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=HENDRIKS S, PEETOOM K, BAKKER C,
et al. Global prevalence of young-onset dementia: a systematic review and meta-analysis [J].
JAMA Neurol, 2021,
78(9): 1080-1090., articleTitle=null, refAbstract=null), Reference(id=1330183579411264146, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Alzheimer’s Disease International, McGill University. World Alzheimer report 2021 [EB/OL]. (2021-09-21)[2022-06-30].
https://www.alzint.org/resource/world-alzheimer-report-2021/., articleTitle=null, refAbstract=null), Reference(id=1330183579474178707, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=KOJOK L, BODENSTEIN K, RIVEST-BEAUREGARD M,
et al. Anxiety and depression among Chinese adolescents during the COVID-19: an overestimation of the problem[J].
Transl Psychiatry, 2021,
11(1): 624., articleTitle=null, refAbstract=null), Reference(id=1330183579537093268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Anon. Depression [EB/OL]. (2021-09-13)[2022-06-30].
https://www.who.int/news-room/fact-sheets/detail/depression., articleTitle=null, refAbstract=null), Reference(id=1330183579620979349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=MCINTYRE R S, BERK M, BRIETZKE E,
et al. Bipolar disorders [J].
Lancet, 2020,
396(10265): 1841-1856., articleTitle=null, refAbstract=null), Reference(id=1330183579675505302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=JARDRI R, DUVERNE S, LITVINOVA A S,
et al. Experimental evidence for circular inference in schizophrenia[J].
Nat Commun, 2017,
8: 14218., articleTitle=null, refAbstract=null), Reference(id=1330183579734225559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Exelon (rivastigmine tartrate) capsules [EB/OL]. (2000-04-21) [2022-06-30].
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20823_Exelon.cfm., articleTitle=null, refAbstract=null), Reference(id=1330183579780362904, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=YOUDIM M B, EDMONDSON D, TIPTON K F. The therapeutic potential of monoamine oxidase inhibitors [J].
Nat Rev Neurosci, 2006,
7(4): 295-309., articleTitle=null, refAbstract=null), Reference(id=1330183579847471769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. New drug application (NDA): 017874 [EB/OL]. (1979-12-31) [2022-06-30].
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017874., articleTitle=null, refAbstract=null), Reference(id=1330183579901997722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=OHI K, TAKAI K, KURAMITSU A,
et al. Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: a 52-week open-label study [J].
Prog Neuropsychopharmacol Biol Psychiatry, 2022,
113:110470., articleTitle=null, refAbstract=null), Reference(id=1330183579969106587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. New drug application (NDA): 021336 [EB/OL]. (2006-02-27) [2022-06-30].
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021336., articleTitle=null, refAbstract=null), Reference(id=1330183580019438236, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=BIRMAHER B, HAFEMAN D, MERRANKO J,
et al. Role of polygenic risk score in the familial transmission of bipolar disorder in youth [J].
JAMA Psychiatry, 2022,
79(2): 160-168., articleTitle=null, refAbstract=null), Reference(id=1330183581642633885, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=BRAUND T A, TILLMAN G, PALMER D M,
et al. Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report [J].
Transl Psychiatry, 2021,
11(1): 417., articleTitle=null, refAbstract=null), Reference(id=1330183581743297182, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=ISMAIL Z, BLACK S E, CAMICIOLI R,
et al. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia [J].
Alzheimers Dement, 2020,
16(8): 1182-1195., articleTitle=null, refAbstract=null), Reference(id=1330183581814600351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=EL-TOKHY F S, ABDEL-MOTTALEB M M A, EL-GHANY E A,
et al. Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia[J].
Int J Pharm, 2021,
608: 121080., articleTitle=null, refAbstract=null), Reference(id=1330183581902680736, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=MECHLER K, BANASCHEWSKI T, HOHMANN S,
et al. Evidence-based pharmacological treatment options for ADHD in children and adolescents [J].
Pharmacol Ther,2022,
230: 107940., articleTitle=null, refAbstract=null), Reference(id=1330183581965595297, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=HASHIMOTO Y, KOTAKE K, WATANABE N,
et al. Lamotrigine in the maintenance treatment of bipolar disorder [J].
Cochrane Database Syst Rev, 2021,
9(9):CD013575., articleTitle=null, refAbstract=null), Reference(id=1330183582024315554, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=MCCUTCHEON R A, REIS MARQUES T, HOWES O D. Schizophrenia - an overview [J].
JAMA Psychiatry, 2020,
77(2): 201-210., articleTitle=null, refAbstract=null), Reference(id=1330183582095618723, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药监局药审中心.国家药监局药审中心关于发布《注意缺陷多动障碍(ADHD)药物临床试验技术指导原则(试行)》的通告(2021年第37号) [EB/OL].(2021-09-13)[2022-06-30].
https://www.cde.org.cn/main/news/viewInfoCommon/2b0f84e0627bf8d61470246373c36c70., articleTitle=null, refAbstract=null), Reference(id=1330183582171116196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=SAYAL K, PRASAD V, DALEY D,
et al. ADHD in children and young people: prevalence, care pathways, and service provision [J].
Lancet Psychiatry, 2018,
5(2): 175-186., articleTitle=null, refAbstract=null), Reference(id=1330183582284362405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LORD C, BRUGHA T S, CHARMAN T,
et al. Autism spectrum disorder [J].
Nat Rev Dis Primers, 2020,
6(1):5., articleTitle=null, refAbstract=null), Reference(id=1330183582355665574, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=OLIVA V, LIPPI M, PACI R,
et al. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis [J].
Prog Neuropsychopharmacol Biol Psychiatry, 2021,
109: 110266., articleTitle=null, refAbstract=null), Reference(id=1330183582431163047, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Assessment report - Intuniv [EB/OL]. (2022-04-10) [2022-06-30].
https://www.ema.europa.eu/en/medicines/human/EPAR/intuniv., articleTitle=null, refAbstract=null), Reference(id=1330183582502466216, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Application number 21346. Clinical pharmacology and biopharmaceutics reviews [EB/OL]. (2003-04-28)[2022-06-30].
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21346_Risperdal%20Consta%20Long-Acting%20Injection_biopharmr.PDF., articleTitle=null, refAbstract=null), Reference(id=1330183582603129514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=QAMAR Z, ASHHAR M U, ANNU,
et al. Lipid nanocarrier of selegiline augmented anti-Parkinson’s effect via P-gp modulation using quercetin [J].
Int J Pharm, 2021,
609:121131., articleTitle=null, refAbstract=null), Reference(id=1330183582670238379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Daytrana (methylphenidate) transdermal system. New drug application (NDA): 021514 [EB/OL]. (2006-04-06)[2022-06-30].
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021514_daytrana_toc.cfm., articleTitle=null, refAbstract=null), Reference(id=1330183582741541548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Drug approval package: XELSTRYM [EB/OL]. (2021-03-22)[2022-06-30].
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/215401Orig1s000TOC.cfm., articleTitle=null, refAbstract=null), Reference(id=1330183582796067501, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Exelon: EPAR - product information [EB/OL]. (2021-01-01)[2022-06-30].
https://www.ema.europa.eu/en/documents/product-information/exelon-epar-product-information_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1330183582968033966, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=ROMPICHERLA S K L, ARUMUGAM K, BOJJA S L,
et al. Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease [J].
Naunyn Schmiedebergs Arch Pharmacol, 2021,
394(8): 1737-1755., articleTitle=null, refAbstract=null), Reference(id=1330183583056114351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Japan Pharmaceuticals and Medical Devices Agency. Rivastigmine [EB/OL]. (2021-04-13)[2022-06-30].
https://www.pmda.go.jp/PmdaSearch/iyakuDetail/GeneralList/1190700., articleTitle=null, refAbstract=null), Reference(id=1330183583144194736, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. New drug application (NDA): 022083 [EB/OL]. (2007-07-06)[2022-06-30].
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022083., articleTitle=null, refAbstract=null), Reference(id=1330183583223886513, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Drug approval package: ADLARITY
® (donepezil transdermal system)[EB/OL]. (2022-03-11)[2022-06-30].
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212304s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1330183583295189682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Japan Pharmaceuticals and Medical Devices Agency. Blonanserin [EB/OL]. (2022-04-01) [2022-06-30].
https://www.pmda.go.jp/PmdaSearch/iyakuDetail/GeneralList/1179700., articleTitle=null, refAbstract=null), Reference(id=1330183583358104243, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Drug approval package: Secuado [EB/OL]. (2019-10-11)[2022-06-30].
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212268Orig1s000TOC.cfm., articleTitle=null, refAbstract=null), Reference(id=1330183583429407412, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=KAMINSKY B M, BOSTWICK J R, GUTHRIE S K. Alternate routes of administration of antidepressant and antipsychotic medications [J].
Ann Pharmacother, 2015,
49(7): 808-817., articleTitle=null, refAbstract=null), Reference(id=1330183583496516277, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN X. Current and future technological advances in transdermal gene delivery [J].
Adv Drug Deliv Rev, 2018,
127: 85-105., articleTitle=null, refAbstract=null), Reference(id=1330183583563625142, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=EL MOUSSAOUI S, FERNÁNDEZ-CAMPOS F, ALONSO C,
et al. Topical mucoadhesive alginate-based hydrogel loading ketorolac for pain management after pharmacotherapy, ablation, or surgical removal in condyloma acuminata [J].
Gels, 2021,
7(1): 8., articleTitle=null, refAbstract=null), Reference(id=1330183583630734007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. FDA Drug Safety Communication: FDA reporting permanent skin color changes associated with use of Daytrana patch (methylphenidate transdermal system) for treating ADHD [EB/OL]. (2016-01-15)[2022-06-30].
https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-reporting-permanent-skin-color-changes-associated-use-daytrana., articleTitle=null, refAbstract=null), Reference(id=1330183583706231480, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=WINBLAD B, GROSSBERG G, FRÖLICH L,
et al. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease [J].
Neurology,2007,
69(4 Suppl 1): S14-S22., articleTitle=null, refAbstract=null), Reference(id=1330183583773340345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=CUMMINGS J L, FARLOW M R, MENG X,
et al. Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease [J].
Clin Drug Investig, 2010,
30(1):41-49., articleTitle=null, refAbstract=null), Reference(id=1330183583907558074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=OWEN M J, SAWA A, MORTENSEN P B. Schizophrenia[J].
Lancet, 2016,
388(10039): 86-97., articleTitle=null, refAbstract=null), Reference(id=1330183583966278331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=FINDLING R L, LANDBLOOM R P, MACKLE M,
et al. Safety and efficacy from an 8 week double-blind trial and a 26 week open-label extension of asenapine in adolescents with schizophrenia [J].
J Child Adolesc Psychopharmacol,2015,
25(5): 384-396., articleTitle=null, refAbstract=null), Reference(id=1330183584037581500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.药物临床试验的一般考虑指导原则[EB/OL].(2017-01-18)[2022-06-30].
https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=b32eaabf2c4cc56570c23c19f9608076., articleTitle=null, refAbstract=null), Reference(id=1330183584092107453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease [EB/OL]. (2018-02-22) [2022-06-30].
https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicines-treatment-alzheimers-disease-revision-2_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1330183584167604926, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.药审中心关于征求《抗精神病药的药物临床试验技术指导原则》意见的通知[EB/OL].(2018-06-28)[2022-06-30].
https://www.cde.org.cn/main/news/viewInfoCommon/8af17d1af2f89cbc88aedf2d59c1392f., articleTitle=null, refAbstract=null), Reference(id=1330183584276656831, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.关于发布双相障碍治疗药物的临床试验技术指导原则的通告(2018年第115号)[EB/OL].(2018-11-06)[2022-06-30].
https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20181108112401469.html., articleTitle=null, refAbstract=null), Reference(id=1330183584347960000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=食品药品监督管理总局.总局关于发布抗抑郁药的药物临床试验技术指导原则的通告(2018年第39号)[EB/OL].(2018-02-27)[2022-06-30].
https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20180227164701847.html., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330183575367955049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, xref=null, ext=[AuthorCompanyExt(id=1330183575380537962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083), AuthorCompanyExt(id=1330183575388926571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183573958668902, companyId=1330183575367955049, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中南大学湘雅药学院,湖南 长沙 410083)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.02.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.02.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.02.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.02.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1675958400000, fullTextJson=null, articleText=null, reference=null)